News
- 
            162024-12Mainly engaged in anti-tuberculosis, antihypertensive/cardiovascular, antibiotics and vitamin derivatives and other categories of apis and intermediates
- 
            132024-12The company is a pharmaceutical enterprise integrating the production and sales of raw materials and intermediates
- 
            102024-12With high quality products and satisfactory service to cooperate with friends at home and abroad, create a better future

 Language
Language

